JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M303710200 on July 18, 2003

J. Biol. Chem., Vol. 278, Issue 39, 36999-37005, September 26, 2003
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/39/36999    most recent
M303710200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Piri, N.
Right arrow Articles by Farber, D. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Piri, N.
Right arrow Articles by Farber, D. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Differential Expression of Rod Photoreceptor cGMP-Phosphodiesterase {alpha} and {beta} Subunits

mRNA AND PROTEIN LEVELS*

Natik Piri {ddagger} §, Clyde K. Yamashita {ddagger}, Jennifer Shih {ddagger}, Novrouz B. Akhmedov {ddagger} and Debora B. Farber {ddagger} § ¶ ||

From the {ddagger}Jules Stein Eye Institute, UCLA School of Medicine and the Molecular Biology Institute, UCLA, Los Angeles, California 90095

Received for publication, April 9, 2003 , and in revised form, July 15, 2003.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
The catalytic core of photoreceptor-specific cGMP-phosphodiesterase (PDE) consists of two subunits, PDE{alpha} and PDE{beta}, that are homologous and have similar domain organization but are encoded by different genes. We have examined the PDE{alpha} and PDE{beta} mRNA steady-state and protein levels as well as the biosynthesis rate of these proteins in developing and fully differentiated retinas. We have also determined the translational efficiency of PDE subunits and the role of their mRNA structures in regulating protein synthesis. In mature retinas, PDE{alpha} and PDE{beta} are represented by ~1.5 x 108 and 7.5 x 108 copies/µg retinal mRNA, respectively. The levels of these transcripts in developing photoreceptors (P10) are approximately 75% of those at P30. Quantification of protein concentration indicated that PDE{alpha} and PDE{beta} are equally expressed in developing and fully differentiated photoreceptors. Furthermore, the PDE{alpha}/PDE{beta} ratios obtained throughout a 2-h pulsechase period revealed a similar turnover rate for both subunits. The observed discordance between the mRNA and protein levels of PDE{alpha} and PDE{beta} suggested post-transcriptional regulation of their expression. We found that PDE{alpha} mRNA is translated more efficiently than either of the two PDE{beta} transcripts expressed in retina. Therefore, the lower level of PDE{alpha} mRNA is compensated by its more efficient translation to achieve equimolar expression with PDE{beta}. We also analyzed the effect of PDE{alpha} and PDE{beta} mRNA 5'- and 3'-untranslated regions as well as that of their coding regions on protein synthesis. We determined that the PDE-coding regions play a critical role in the differential translation of these subunits.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Signal transduction in the vertebrate rod and cone photoreceptors is mediated by a cascade of protein interactions/activations that lead to hydrolysis of cGMP by a photoreceptor-specific cGMP-phosphodiesterase (PDE)1 followed by closure of the cGMP-gated channels on the plasma membrane (1). The catalytic core of cone PDE is composed of two identical {alpha}' subunits, whereas that of the rod enzyme is a heterodimer (PDE{alpha}, 88 kDa and PDE{beta}, 84 kDa) (2, 3). Although each of these three proteins is encoded by a different gene, they share significant homology in both amino acid and nucleotide sequences. Cone and rod PDEs have similar domain organization and contain two cGMP-binding site motifs, a catalytic site and a CAAX box signal for post-translational modification (4). Why the rod holoenzyme consists of two different subunits is still unknown. Based on classical biochemical studies carried out with the bovine rod cGMP-PDE, it has been accepted that PDE{alpha} and PDE{beta} are present in a 1:1 ratio and that they are assembled in a heterodimeric catalytic core (2, 3, 5). This coordinated expression of PDE{alpha} and PDE{beta} in rod photoreceptors must be regulated at the transcriptional and/or post-transcriptional level so that a final equimolar ratio of these proteins is achieved. However, there is some indirect evidence suggesting the possibility that the rod PDE catalytic core is not only present as a heterodimer but also as {alpha}{alpha} and {beta}{beta} homodimers (6), similar to cone {alpha}'{alpha}' PDE. We have previously demonstrated that the individually expressed catalytic subunits have PDE enzymatic activity (7), supporting the idea of independent catalytic motifs on PDE{alpha} and PDE{beta}. Thus, PDE{alpha} and PDE{beta} may be present in photoreceptor cells at any ratio depending on their expressional "strength."

The proteins of the phototransduction cascade, PDE in particular, have been extensively studied for many years. However, very little is known regarding the regulation of PDE{alpha} and PDE{beta} expression at either the transcriptional or translational level. Although the 5'-flanking regions of PDE{alpha} and PDE{beta} genes have been cloned and sequenced, a detailed analysis that would allow us to speculate about the possible mechanisms of coordinated expression of these genes has not been carried out. A sequence analysis of the 5'-flanking regions of the PDE{alpha} and PDE{beta} revealed two common potential regulatory elements: a Ret1-like site, the binding site for the retina-specific Ret1 transcription factor (8), and a GC box, the binding site for the SP family of transcription factors. Work coming out from our laboratory has implicated Sp4 in the transcriptional regulation of PDE{beta} (9, 10), but the effect of this factor on PDE{alpha} has not yet been established.

This study was initiated with the intention of: 1) determining the PDE{alpha} and PDE{beta} mRNA steady-state levels as well as protein levels in the mouse retina at different stages of photoreceptor development; 2) examining the turnover of translated PDE{alpha} and PDE{beta} by pulse-chase labeling and immunoprecipitation to determine whether the final stoichiometric amounts of the catalytic subunits are the result of differences in either efficiency of translation or post-translational protein stability; and 3) determining the PDE{alpha} and PDE{beta} mRNA translational efficiency and the role of their 5'-UTRs, coding regions, and 3'-UTRs in protein synthesis.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
RNA Isolation and in Vitro Transcription—Total RNA was extracted from 10- and 30-day-old normal mouse retinas using RNAzol B (Tel-Test, Friendswood, TX). mRNA was isolated using the mRNA purification kit (Amersham Biosciences). Concentrations of the RNA samples were determined by measuring their optical density.

For in vitro transcription, the cDNAs were subcloned into the pGEM3Z vector (Promega, Madison, WI) between BamHI and SalI. In vitro transcription was performed using 1 µg of linearized DNA and the T7 mMessage mMachine kit (Ambion, Austin, TX) according to the manufacturer's protocol. The length and the concentration of the synthesized transcripts were determined by running an aliquot on a denaturing agarose gel as recommended by Ambion. Quantification of the samples was performed using the two-dimensional spot densitometry program of the Alpha Imager 2000 (Alpha Innotec, San Leandro, CA).

RT-PCR Analysis—First strand cDNA was synthesized using murine leukemia virus reverse transcriptase (PerkinElmer Life Sciences), 0.75 mM of antisense primer, 1 mM dNTPs, 10 units of RNAsin (Promega), 5 mM MgCl2, 10 mM Tris-HCl, pH 8.3, and 50 mM KCl. The reaction mixture was incubated at 42 °C for 15 min. PCR was performed with AmpliTaq DNA polymerase (PerkinElmer Life Sciences), 0.75 mM antisense and sense primers, 2 mM MgCl2, 10 mM Tris-HCl, pH 8.3, and 50 mM KCl. The PCR profile time and temperature were as follows: denaturation at 94 °C for 2 min, annealing at 57 °C for 1 min 20 s, and extension at 72 °C for 1 min 30 s with a final elongation step at 72 °C for 5 min.

Quantitative Northern Blot and Quantitative RT-PCR—mRNAs (2 µg) were separated by electrophoresis in a 1.2% agarose gel containing 2.2 M formaldehyde, transferred to Hybond-N+ (Amersham Biosciences), cross-linked, and hybridized with random-labeled PDE{alpha} and PDE{beta} cDNA fragments. Autoradiographs were analyzed using the two-dimensional spot densitometry program of the Alpha Imager 2000 to determine the intensity of the hybridization signals.

Quantification of the PDE{beta} transcripts differing by the length of their 5'-UTRs was based on the PCR method described by Riedy et al. (11). A competitive reference standard RNA (RNA-CRS) was obtained as follows: cDNA fragments with a 75-nucleotide deletion were synthesized by PCR using primers MB7 (5'-CGGGATCCTGCAGAATCCATGTGTACC-3') and MB45 (5'-TGCGGTCGACAGGATCTTGAAGACCACACGTTCCAAGGCTGCCACAGTCCGCCAG-3') and full-length PDE{beta} as template. The resulting product was subcloned into the pGEM3Z vector between BamHI and SalI, and the RNA-CRS was synthesized using the T7 mMessage mMachine kit as described above.

Total retinal RNA and serial dilutions of RNA-CRS were used in RT-PCR with appropriate primer pairs (MB4 5'-TGCAGAATCCATGTGTACCTGGGGG-3' and MB25 5'-AGGATCTTGAAGACCACACGTTCCA-3' for amplification of the long PDE{beta} transcript and MB5 5'-ACAGCAGCAGGAACACCATGAGCCT-3' and MB25 for both the long and short transcripts) to obtain data for mRNA quantification curves. Conditions for RT-PCR were the same as described above. Aliquots from each reaction were electrophoresed in a 2% agarose gel and stained with 0.5 mg/ml ethidium bromide, and the bands were quantified using the spot densitometry function of the Alpha Imager 2000. Since the RNA-CRS cDNA is smaller in size than the wild type cDNA, the decrease in ethidium bromide incorporation was taken into account by using a correction equation (12).

In Vitro Translation—Equal amounts of in vitro synthesized RNAs were used for all of the in vitro translation studies. In vitro translation reactions were performed in the presence of L-[35S]methionine with the retic lysate IVT kit (Ambion) according to the manufacturer's protocol. Translation products were separated by SDS-polyacrylamide gel electrophoresis (6.5% acrylamide, 1.5% bis-acrylamide) using the Tris-Tricine buffer system as previously described (13). The gels were then fixed, stained with Coomassie Blue G-250, dried, and exposed to x-ray film. Proteins were quantified by densitometry of the autoradiograph or direct scintillation counting of the excised bands.

RNA Secondary Structure Prediction and Analysis—5'-UTRs of PDE{alpha} and PDE{beta} mRNAs were analyzed for the presence of stem-loop structures using the RNA Secondary Structure Prediction Program of Genebee Services (www.genebee.msu.su/services/rna2_reduced.html) that determines the most stable structures and their free energy level. PSORT II (psort.nibb.ac.jp/), SubLoc v1.0 (www.bioinfo.tsinghua-.edu.cn/SubLoc/), and the Predict NLS (cubic.bioc.columbia.edu/predict-NLS/) were used to determine subcellular localization of the PDE{alpha} and PDE{beta} subunits.

Preparation of Mouse Rod Outer Segments (ROS) and Immunoblot Analysis—An analysis of the stoichiometric amounts of PDE{alpha} and PDE{beta} subunits was performed on retinas from 10- and 30-day-old animals and on sealed ROS isolated from 48 adult (greater than 30 days of age) C57/Bl retinas by sucrose gradient centrifugation according to the method of Papermaster (14). Proteins (50 µg of total protein/lane from retinal homogenates and 8 µg of total protein/lane from ROS) were separated by Tris-Tricine-buffered inverted gradient gel electrophoresis (13) and transferred to nitrocellulose membrane (15). Membranes were blocked in either 3% bovine serum albumin, 0.1% Tween 20 in Tris-buffered saline (500 mM NaCl, 20 mM Tris, pH 7.6) or 0.3% Tween 20 in Tris-buffered saline for colloidal gold staining. Immunoblots were incubated with a polyclonal peptide antiserum ({alpha}T1) previously characterized (7), and the signal was amplified with a goat anti-rabbit biotinylated secondary antibody and AvidinD/biotin-coupled horseradish peroxidase (Vector Laboratories, Burlingame, CA). Blots were visualized with the ECL kit (Amersham Biosciences) on Hyperfilm-MP pre-flashed according to the SensitizeTM protocol (Amersham Biosciences) to increase the range of film exposure linearity. Films were developed and scanned densitometrically on a Pharmacia/LKB XL densitometer (Amersham Biosciences).

Labeling and Immunoprecipitation—Mice were sacrificed at 10 post-natal days (according to the guidelines of the UCLA Committee on Animal Research and the Association for Research in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic and Vision Research) and enucleated, and the eyes were hemisected. The resulting eyecups were incubated in HEPES-buffered Medium 199 with Hanks' salts without dl-methionine (Invitrogen) for 30 min at 37 °C in a 95% O2, 5% CO2 incubator to methionine-deplete the tissue. The eyecups were then incubated with L-[35S]methionine (1000 Ci/mmol and 100 µCi/ml media, Amersham Biosciences) for 3 h and subsequently washed and incubated in fresh Medium 199 supplemented with cold l-methionine at 500 µM final concentration. At the appropriate times, eyecups were removed and the retinas were dissected and immediately frozen at –80 °C on dry ice to prevent further incorporation of label and protein degradation. Retinas were homogenized with hypotonic buffer, and aliquots were removed to determine trichloroacetic acid-precipitable counts and protein concentration by the method of Peterson (16) using bovine serum albumin as standard.

Immunoprecipitation was carried out as described previously (17) using a polyclonal rod cGMP-PDE-specific antiserum, MOE (18). Proteins were separated by a Tris-Tricine-buffered inverted gradient sodium dodecyl sulfate-polyacrylamide gel as described previously (13) for 22 h at 35 mA constant current. Proteins were then blotted to nitrocellulose membrane, stained with Aurodye total protein stain (Bio-Rad), and exposed to autoradiography on pre-flashed Hyperfilm-MP.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Quantification of PDE{alpha} and PDE{beta} mRNAs by Northern Blot Hybridization—This method for absolute quantification of specific mRNAs is based on the generation of a standard curve using known amounts of an external standard (synthetic sense strand RNA with identical sequence to the target mRNA) and interpolation of the concentration of the target mRNA from the curve. The external standards for PDE{alpha} and PDE{beta} mRNA quantification were synthesized in vitro from constructs containing full-length PDE{alpha} and PDE{beta} cDNAs. mRNA samples isolated from 10- and 30-day-old mouse retinas were hybridized with the random-labeled PDE{alpha} and PDE{beta} cDNA fragments. Two transcripts with molecular masses of 3.0 and 2.8 kb corresponding to the PDE{alpha} and PDE{beta} mRNAs, respectively, were hybridized. Using the external standard curve, we determined that in the 30-day-old mouse retina the level of PDE{alpha} transcript was 1.5 ± 0.05 ng and that of PDE{beta} transcript was 0.34 ± 0.02 ng/1 µg of retinal mRNA (Fig. 1). Based on the molecular masses of PDE{alpha} and PDE{beta} transcripts (1.03 x 106 and 0.87 x 106, respectively) we estimated that 1 µg of retinal mRNA contains ~1.5 x 108 (±0.2 x 108) and 7.5 x 108 (±0.5 x 108) PDE{alpha} and PDE{beta} transcripts, respectively. Similar quantification carried out with mRNA samples of 10-day-old mouse retina (Fig. 1) showed that at this age the concentration of PDE{alpha} and PDE{beta} transcripts is ~75% of that in the 30-day-old retina. The levels reported are the average of those determined in three different experiments.



View larger version (17K):
[in this window]
[in a new window]
 
FIG. 1.
Quantitative Northern blot analysis of mouse rod PDE{alpha} (a) and PDE{beta} (b) mRNAs. Randomly labeled PDE{alpha} (1–300 nucleotides) and PDE{beta} (1–298 nucleotides) cDNA fragments were used as probes. Lanes 1 and 2 contain 2 µg of retinal mRNA isolated from 10- and 30-day-old mouse retinas, respectively. Lanes 3–6 contain serial dilutions of the in vitro synthesized PDE{alpha} and PDE{beta} RNAs. Lane 3, 2 ng; lane 4, 4 ng; lane 5, 8 ng; and lane 6, 16 ng.

 

Quantitative RT-PCR Analysis of mRNAs—It had been reported previously (19) that mouse PDE{beta} has two different transcription start sites represented in the retina by two transcripts, one with a 59-nucleotide 5'-UTR and the other with a 34-nucleotide 5'-UTR. Because the 5'-UTR is a major element implicated in mRNA translation, the two PDE{beta} transcripts could have different translation initiation strengths. Therefore, any changes in the molar ratio of these transcripts during the development of photoreceptor cells could be responsible for modulation of PDE{beta} protein concentration.

Quantitative RT-PCR was used to determine the level of the PDE{beta} transcript with long 5'-UTR and the total concentration of PDE{beta} mRNA (the sum of the long and short transcripts) in the 10- and 30-day-old mouse retina. This technique involves the use of an RNA-CRS that is identical in sequence to the wild type mRNA with the exception of an internal nucleotide deletion. Primers MB4 and MB25 were used to amplify the long transcript, and primers MB5 and MB25 were used to amplify at the same time both the long and the short transcripts. PCR products were separated by gel electrophoresis, stained with ethidium bromide, and analyzed densitometrically (Fig. 2, Ia, Ib, IIa, and IIb). The concentration of the RNA-CRS (x axis) was plotted versus the ratio of the RNA-CRS to the wild type mRNA band densities (Fig. 2, Ic and IIc, y axis). The concentration of PDE{beta} mRNA corresponds to the point on the x axis where the ratio RNA-CRS:PDE{beta} mRNA is 1. The results of these experiments indicate that both long and short PDE{beta} transcripts are represented at equimolar concentrations in the photoreceptor cells of the 10- and 30-day-old animals.



View larger version (38K):
[in this window]
[in a new window]
 
FIG. 2.
Quantification of PDE{beta} long and short transcripts. Variable template concentrations of the reference standard (RNA-CRS) were used along with RNA isolated from 10- and 30-day-old mouse retinas in competitive RT-PCR. Ia and Ib, PCR products obtained using 10-day-old mouse retinal RNA and primer pairs MB4+MB25 (298 and 223 bp) and MB5+MB25 (256 and 181 bp), respectively. IIa and IIb, PCR products obtained using 30-day-old mouse retinal RNA and primer pairs MB4+MB25 (298 and 223 bp) and MB5+MB25 (256 and 181 bp), respectively. M, kilobase DNA ladder. Lanes 1–3 contain PCR products obtained using 0.4 µg of total retinal RNA and 48.2, 24.1, and 9.6 attomol RNA-CRS, respectively. Lanes 4, PCR using only 48.2 attomol RNA-CRS. Lanes 5, PCR using only 0.4 µg of total retinal RNA. Ic and IIc, the concentration of RNA-CRS is plotted against the ratio of RNA-CRS:PDE{beta} RNA band densities. Equivalence points were determined from the curve.

 

Western Blot Analysis—Given the 5-fold difference in transcript abundance observed by quantitative Northern blots, we had to establish the protein subunit stoichiometry in the mouse retina. We accomplished this by utilizing {alpha}T1, an antibody that recognizes the same epitope on both PDE{alpha} and PDE{beta}. The relative amounts of PDE{alpha} and PDE{beta} were obtained by determining the corresponding integrated areas of the optical density peaks (IOD) and then the ratio of PDE{alpha} IOD to PDE{beta} IOD (Fig. 3). Ratios of ~1:1 were obtained for all three of the samples analyzed, confirming equimolar expression of PDE{alpha} and PDE{beta} subunits in mouse rod photoreceptors, similar to what is seen for the bovine enzyme.



View larger version (61K):
[in this window]
[in a new window]
 
FIG. 3.
Western blot and densitometric analysis of proteins from mouse ROS and retinal samples. Panel a, gold staining of ROS and retinal proteins (10 µg/lane) separated by SDS-PAGE. Panel b, immunoblot incubated with {alpha}T1 antiserum. The calculated ratios (PDE{alpha}/PDE{beta}) of IOD were obtained from densitometric scanning of the immunoblot.

 

Biosynthesis and Turnover—Using L-[35S]methionine, we performed pulse-chase labeling of newly synthesized PDE subunits followed by immunoprecipitation with a specific polyclonal rod cGMP-PDE antiserum to confirm that the differences observed between protein and corresponding mRNA levels were the result of differential protein translation and/or turnover. The autoradiograph of the gel containing the immunoprecipitated proteins (Fig. 4) was scanned densitometrically, and the IODs were obtained. The rate of L-[35S]methionine incorporation was higher for PDE{alpha} than PDE{beta} as indicated by values greater than 1.0 throughout the course of the experiment for the PDE{alpha}/PDE{beta}-calculated IOD ratios. However, the range of observed IOD ratios from 1.20 to 1.41 suggests that the turnover rate for PDE{beta} is not significantly greater than for PDE{alpha}, particularly when the difference in the molar methionine content of PDE{alpha} and PDE{beta}, 34 residues and 29 residues, respectively, is taken into account.



View larger version (56K):
[in this window]
[in a new window]
 
FIG. 4.
Pulse-chase labeling of newly synthesized PDE subunits. Autoradiograph of PDE{alpha} and PDE{beta} subunits immunoprecipitated with a polyclonal PDE antiserum after a 0-, 0.5-, 1-, and 2-h pulse. The calculated PDE{alpha}/PDE{beta} IOD ratios at the corresponding time points are shown at the bottom of each lane.

 

Translational Efficiency of the Full-length PDE{alpha} and PDE{beta} mRNAs—To determine the translational efficiency of the PDE{alpha} and PDE{beta} mRNAs, three constructs were prepared by subcloning the PDE{alpha} and PDE{beta} (B5s and B5l) cDNAs into the pGEM3Z vector (Fig. 5, Ia). The PDE{beta} subunit is represented by two constructs since mouse photoreceptor cells express two PDE{beta} transcripts that differ in the length of their 5'-UTRs. Capped mRNAs were in vitro transcribed from the A, B5s, and B5l templates, transcripts were quantified by both spectrophotometry and spot densitometry, and equal amounts of each mRNA were used for in vitro translation in the presence of L-[35S]methionine. As a first step in the analysis of the translational efficiency of PDE{alpha} and PDE{beta}, we determined the approximate linear range of protein synthesis and the relative stability of the corresponding mRNAs in the reticulocyte lysate. In pilot studies, the in vitro translation reactions with A, B5s, and B5l mRNAs were incubated for 20, 40, or 60 min. The RNA from each reaction was then extracted and analyzed by slot-blot hybridization. No noticeable mRNA degradation was observed during incubation for up to 60 min. Synthesized proteins were separated by PAGE, and their amount was determined by measuring L-[35S]methionine incorporation. The results obtained showed that at 60 min but not after 20 or 40 min of incubation, protein synthesis reached saturation. Based on these observations, all of the reactions for quantitative analysis were performed for 30 min.



View larger version (47K):
[in this window]
[in a new window]
 
FIG. 5.
Quantitative analysis of the in vitro synthesized PDE{alpha} and PDE{beta} proteins. Ia, constructs corresponding to the wild type PDE{alpha} and PDE{beta} mRNA. IIa, constructs obtained by swapping 5'-UTRs between PDE{alpha} and PDE{beta} cDNAs. IIIa, constructs obtained by mutating the G at the +4 position in the translation initiation sequence (B5sM and B5lM) or by mutating an upstream AUG in the long 5'-UTR (B5lM2). IVa, constructs obtained by exchanging the 3'-UTRs of PDE{alpha} and the two PDE{beta} cDNAs. Ib, IIb, IIIb, and IVb, autoradiographs of the PDE{alpha} and PDE{beta} in vitro synthesized using the indicated constructs. Ic, IIc, IIIc, and IVc, quantification of the in vitro synthesized PDE{alpha} and PDE{beta} based on L-[35S]methionine incorporation. The different regions of PDE{alpha} and PDE{beta} mRNAs are shown in the constructs as follows: diagonal stripes, PDE{alpha} 5'-UTR; white area, PDE{alpha}-coding region; vertical stripes, PDE{alpha} 3'-UTR; black area, PDE{beta} 5'-UTR; gray shading, PDE{beta}-coding region; and horizontal stripes shaded, PDE{beta} 3'-UTR.

 

mRNA synthesized from constructs A, B5s, and B5l yielded products with the expected molecular masses of 88 and 84 kDa, corresponding to PDE{alpha} and PDE{beta}, respectively, but exhibited differential translational efficiency (Fig. 5, Ib). The synthesized PDE{alpha} was ~4.5-fold more abundant than PDE{beta} synthesized from the short transcript (B5s) and 5.0-fold more abundant than PDE{beta} produced from the long transcript (B5l) (Fig. 5, Ib and Ic). A low level of protein synthesis from B5l was anticipated since this mRNA contains in the 5'-UTR an upstream AUG known to have a negative effect on translation. Thus, constructs A, B5s, and B5l enabled us to determine the differences in PDE{alpha} and PDE{beta} protein synthesis efficiency resulting from the contribution of the full-length mRNAs. The input of the coding regions and 5'- and 3'-UTRs of each of these mRNAs in the differential translation of PDE{alpha} and PDE{beta} was assessed in the experiments described below.

The Role of the 5'-UTR in PDE{alpha} and PDE{beta} mRNA Translation—The 5'-UTR is known to be an essential factor in determining the rate of translation initiation (20, 21) and consequently the overall protein synthesis efficiency. We hypothesized that if the 5'-UTRs of PDE{alpha} or PDE{beta} were solely responsible for the observed differences in efficiency of translation, the exchange of these regions between the subunits would lead to opposite results to those obtained with the original A, B5s, and B5l constructs. That is, the exchange of 5'-UTRs would produce approximately 5 times more PDE{beta} than PDE{alpha}. However, the chimeric constructs shown in Fig. 5, IIa, gave results different from what was expected. The amount of protein synthesized using construct A5B (containing PDE{alpha} 5'-UTR, PDE{beta}-coding region, and 3'-UTR) was ~5.5-fold lower than that produced by the native PDE{alpha} transcript (construct A) and slightly less than that produced by B5s or B5l (Fig. 5, IIb and IIc and Ia, Ib, and Ic). In contrast, the placement of the PDE{beta} short 5'-UTR in front of the PDE{alpha}-coding region and 3'-UTR (construct B5sA) resulted in greater protein synthesis than that produced by the original A (~2-fold), B5s (~8-fold), or B5l (~10-fold) constructs. Similarly, the placement of the PDE{beta} long 5'-UTR in front of the PDE{alpha}-coding region and 3'-UTR (construct B5lA) also increased protein synthesis above the levels produced by the native mRNAs, although this construct was ~1.8-fold less efficient than B5sA with the PDE{beta} short 5'-UTR. This reduction in efficiency of translation of construct B5lA when compared with B5sA is possibly due to the presence of the AUG upstream of the translation initiation site. These experiments clearly demonstrated the negative impact of the PDE{alpha} 5'-UTR on the rate of protein synthesis.

The Effect of a Non-consensus Translation Initiation Sequence and of the Upstream AUG in the 5'-UTR on PDE{beta} mRNA Translation—It has been shown that both the absence of a "strong" translation initiation sequence (2224) and the presence of an upstream AUG (2527) can result in lower protein synthesis efficiency. In addition to the upstream AUG in its long 5'-UTR, the PDE{beta} mRNA translation initiation sequence is not in absolute agreement with the Kozak consensus sequence (there is an A instead of G at the +4 position). To find out whether these sequences have a negative effect on PDE{beta} translation, three new constructs were created by site-directed mutagenesis (Fig. 5, IIIa). Two of the constructs, B5sM and B5lM, were obtained by replacing the A at the +4 position of PDE{beta} mRNA with G, creating in this way the consensus translation initiation sequence. As expected, the amount of protein synthesized from the mutated short transcript was ~2.6-fold higher than that obtained from B5s mRNA (Fig. 5, IIIb and IIIc and Ib and Ic). Thus, the absence of a Kozak sequence reduces translational efficiency of PDE{beta}. However, the A to G mutation at the +4 position in the transcript with the long 5'-UTR did not affect its translational rate. This may again be attributed to the presence of the upstream AUG in the long 5'-UTR. To test this possibility, we generated the third construct, B5lM2, by mutating the upstream AUG of the long PDE{beta} transcript to AAG. Indeed, protein synthesis from this construct was 2.2 times more abundant than that from the wild type B5l transcript (Fig. 5, Ib and Ic and IIIb and IIIc).

The Role of the 3'-UTRs in PDE{alpha} and PDE{beta} Translation Efficiency—Along with the 5'-UTR, the 3'-UTR is emerging as another important mRNA sequence controlling its translation (2830). To determine the contribution of the PDE{alpha} and PDE{beta} mRNA 3'-UTR on protein synthesis, three chimeras were constructed by exchanging the 3'-UTRs of constructs A and B5s or B5l (Fig. 5, IVa). AB3 was translated only 1.3 times more efficiently than construct A. In contrast, the placement of PDE{alpha} 3'-UTR in the B5sA3 construct increased protein production by close to 3-fold (Fig. 5, IVb and IVc and Ib and Ic). However, protein synthesis by B5lA3 construct was similar to that produced by B5l, again suggesting a repressing effect of the upstream AUG in the long PDE{beta} 5'-UTR. Swapping 3'-UTRs between PDE subunits did not reverse their translational efficiency, i.e. protein synthesis from PDE{alpha} mRNA was greater than that from PDE{beta}.

A comparison of the levels of protein synthesized from all of the constructs described in this study demonstrates that those with the PDE{alpha}-coding region, regardless of which flanking 5'- or 3'-UTR they may contain, produce more protein than any construct with the PDE{beta}-coding region.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
As a first step toward understanding the mechanisms of PDE{alpha} and PDE{beta} gene expression, we determined the steady-state levels of PDE{alpha} and PDE{beta} mRNAs and examined the biosynthesis/turnover of the translated PDE{alpha} and PDE{beta} in the developing and fully differentiated mouse retina. Our results indicate that the mRNA for PDE{beta} at both 10- and 30-post-natal days is ~5-fold more abundant than the mRNA for PDE{alpha}. Despite the fact that the PDE{alpha}:PDE{beta} mRNA ratio we observed by quantitative Northern analysis is larger than that observed by Phelan and Bok (31) in 10-day-old mouse retinas using quantitative RT-PCR (this variability could be due to the different techniques used to determine the mRNA levels), both studies as well as results from Y79 cells (32) indicate a higher number of transcripts for PDE{beta} than for PDE{alpha}. In contrast, the examination of protein levels showed equimolar expression and similar turnover rates of PDE{alpha} and PDE{beta} subunits. This discordance between PDE{alpha} and PDE{beta} steady-state mRNA and protein levels suggested that photoreceptor cells must have a mechanism for post-transcriptional regulation of PDE expression.

In this study, we were able to conclusively demonstrate that PDE{alpha} mRNA is translated ~5 times more efficiently than its PDE{beta} counterpart. Thus, the low level of PDE{alpha} mRNA found in retina could be counterbalanced by its efficient translation if PDE{alpha} and PDE{beta} mRNAs are translated in photoreceptor cells with a similar efficiency to that we observed in vitro. Our data also point to possible regulation of PDE expression in photoreceptor cells by the feedback mechanism, i.e. if one of the subunits is being translated in excess it could by itself or through interaction with other factors stimulate or inhibit transcription of the less or more abundant subunit mRNA, respectively. This regulatory mechanism would require translocation of transcription factors from the cytoplasm to the nucleus. Alternatively, signals could be delivered from the cytosol to the nucleus by protein kinases that would activate transcription factors by phosphorylation. It has been shown that proteins with a molecular size of <50 kDa can freely enter the nucleus but that larger proteins must have a nuclear localization sequence (NLS) that is recognized by the members of the importin/karyopherin superfamily. The complex between importin/karyopherin and the NLS-containing protein can then be actively transported through the nuclear pore complex (33, 34). To check the possibility of PDE subunits (PDE{alpha}, 88 kDa and PDE{beta}, 84 kDa) directly regulating their own transcription, we analyzed these proteins using Predict NLS: Prediction and Analysis of NLSs, PSORT II: Prediction of Protein Sorting Signals and Localization Sites in Amino Acid Sequences, and SubLoc (Version 1.0): Subcellular Localization Prediction of Eukaryotic Proteins. This analysis predicted no nuclear localization of PDE{alpha} and PDE{beta} and revealed no potential NLS in their sequences, suggesting that the proposed feedback mechanism would require the involvement of other factors regulating their transcription.

After determining the translational efficiency of PDE{alpha} and PDE{beta} mRNAs, we evaluated the roles of their 5'- and 3'-UTRs known to be involved in controlling protein synthesis as well as that of their coding sequences on this process. Since neither of the 5'-UTRs of PDE{alpha} and PDE{beta} mRNAs contains stable secondary structures that can reduce the rate of protein synthesis, we first hypothesized that the presence of an upstream AUG and the absence of a strong initiation sequence in the 5'-UTR of PDE{beta} mRNA could account for its lower protein synthesis efficiency. Indeed, when the upstream AUG was mutated and the consensus translation initiation sequence in the PDE{beta} mRNA was restored, the protein production was increased. However, using several chimeric constructs, we demonstrated that in fact the 5'-UTR of PDE{alpha} leads to lower protein synthesis than the 5'-UTR of PDE{beta} mRNA. Therefore, the differential translation of the PDE subunits cannot be explained by the differences in the primary or secondary structures of their 5'-UTRs.

The results of our studies undoubtedly implicate the involvement of the coding regions in the differential translation of PDE{alpha} and PDE{beta} mRNAs. All of the eight constructs containing the PDE{beta}-coding region resulted in lower protein expression than the four constructs containing the PDE{alpha}-coding region, regardless of the flanking 5'-or3'-UTR they had. Regulation of protein synthesis by the mRNA-coding region is not a widespread phenomenon. One example of this type of regulation is provided by the response of HSP70 to a heat shock, which involves an increase of the elongation rate (35). It has also been shown that some mRNAs contain in the coding region secondary structures that lead to "ribosomal pause" (36). Liebhaber et al. (37) have shown that extensive secondary structures in the coding region suppresses translation to a minimal or to a substantial degree depending on the distance of these structures from the initiation codon. Coding region duplexes in close proximity to the AUG dramatically suppress translation, whereas duplexes further downstream in the coding region have a milder effect on protein synthesis. We have analyzed PDE{alpha} and PDE{beta} mRNAs for the presence of stable secondary structures. The overall {Delta}G of PDE{alpha} mRNA is –680.7 kcal/mol, and the most stable structure ({Delta}G = –17.8 kcal/mol) proximal to the initiation codon is created by the coding region sequences 5'-GAGGAGGT-3' (position +15 to +22) and 5'-CTCCTCCA-3' (position +107 to +100). Structures with lower {Delta}G (–20.4 and –20.3 kcal/mol) are located ~900 and 1800 nucleotides from the AUG start codon, respectively. The total free energy of the PDE{beta} mRNA is –593.4 kcal/mol. It has six structures with {Delta}Gs ranging from –19.0 to –23.5 kcal/mol. One of these structures ({Delta}G = –19.0 kcal/mol) is in very close proximity to the AUG start codon and involves sequences 5'-GGCACAGC-3' (position –20 to –13 in the 5'-UTR) and 5'-CCGTGTCG-3' (+164 to +147 in the coding region). It will be interesting to determine the involvement of these predicted structures in the regulation of PDE translation.

In summary, our results indicate that the low level of PDE{alpha} mRNA found in retina can be compensated by its more efficient translation to achieve equimolar expression with PDE{beta}. Moreover, our results indicate that the PDE{alpha}- and PDE{beta}-coding regions are responsible for the differential expression of these subunits.


    FOOTNOTES
 
* This work was supported by grants from the NEI, National Institutes of Health (EY02651) and the Foundation for Fighting Blindness. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

|| Recipient of a Senior Scientist Investigators Award from Research to Prevent Blindness. Back

§ To whom correspondence may be addressed: Jules Stein Eye Institute, UCLA School of Medicine, 100 Stein Plaza, Los Angeles, CA 90095. Tel.: 310-825-9850; Fax: 310-794-2144; E-mail: piri{at}jsei.ucla.edu (N. P.) or Tel.: 310-206-7375; Fax: 310-794-7904; E-mail: farber{at}jsei.ucla.edu (D. B. F.).

1 The abbreviations used are: PDE, phosphodiesterase; RT, reverse transcriptase; CRS, competitive reference standard; Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine; UTR, untranslated region; ROS, rod outer segments; IOD, integrated areas of the optical density peaks; NLS, nuclear localization sequence. Back


    ACKNOWLEDGMENTS
 
We thank Dr. Bernard Fung for the gift of the polyclonal antiserum MOE against PDE.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Beavo, J. A. (1995) Physiol. Rev. 75, 725–748[Abstract/Free Full Text]
  2. Baehr, W., Devlin, M. J., and Applebury, M. L. (1979) J. Biol. Chem. 254, 11669–11677[Free Full Text]
  3. Deterre, B., Bigay, J., Forquet, F., Robert, M., and Chabre, M. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 2424–2428[Abstract/Free Full Text]
  4. Stroop, S., and Beavo, J. A. (1992) in Advances in Second Messenger and Phosphoprotein Research (Strada, S. J., and Hidaka, H., eds) Vol. 25, pp. 55–71, Raven Press, Ltd., New York[Medline] [Order article via Infotrieve]
  5. Fung, B. K. K., Young, J. H., Yamane, H. K., and Griswold-Prenner, I. (1990) Biochemistry 29, 2657–2664[CrossRef][Medline] [Order article via Infotrieve]
  6. Artemyev, N. O., Surendran, R., Lee, J. C., and Hamm, H. E. (1996) J. Biol. Chem. 271, 25382–25388[Abstract/Free Full Text]
  7. Piriev, N. I., Yamashita, C., Samuel, G., and Farber, D. B. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 9340–9344[Abstract/Free Full Text]
  8. Morabito, M. A., Yu, X., and Barnstable C. J. (1991) J. Biol. Chem. 266, 9667–9672[Abstract/Free Full Text]
  9. Lerner, L. E., Gribanova, Y. E., Ji, M., Knox, B. E., and Farber, D. B. (2001) J. Biol. Chem. 276, 34999–35007[Abstract/Free Full Text]
  10. Lerner, L. E., Gribanova, Y. E., Whitaker, L., Knox, B. E., and Farber, D. B. (2002) J. Biol. Chem. 277, 25877–25883
  11. Riedy, M. C., Timm, E. A., Jr., and Stewart, C. C. (1995) BioTechniques 18, 70–76[Medline] [Order article via Infotrieve]
  12. Menzo, S., Bannarelli, P., Giacca, M., Manzin, A., Varaldo, P. E., and Clementi, M. (1992) J. Clin. Microbiol. 30, 1752–1757[Abstract/Free Full Text]
  13. Tsang, S. H., Gouras, P., Yamashita, C. K., Kjeldbye, H., Fisher, J., Farber, D. B., and Goff, S. P. (1996) Science 272, 1026–1029[Abstract]
  14. Papermaster, D. S. (1982) Methods Enzymol. 81, 48–52[Medline] [Order article via Infotrieve]
  15. Towbin, H., Staehlin, T., and Gordon, J. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 4350–4354[Abstract/Free Full Text]
  16. Peterson, G. L. (1977) Anal. Biochem. 83, 346–356[CrossRef][Medline] [Order article via Infotrieve]
  17. Farber, D. B., Park, S., and Yamashita, C. (1988) Exp. Eye Res. 4, 363–374
  18. Fung, B. K. K., and Griswold-Prenner, I. (1989) Biochemistry 28, 3133–3137[CrossRef][Medline] [Order article via Infotrieve]
  19. Di Polo, A., Rickman, C. B., and Farber, D. B. (1996) Invest. Ophthalmol. Visual Sci. 37, 551–560[Abstract/Free Full Text]
  20. Day, D. A., and Tuite, M. F. (1998) J. Endocrinol. 157, 361–371[Abstract]
  21. van der Velden, A. W., and Thomas, A. A. (1999) Int. J. Biochem. Cell Biol. 31, 87–106[CrossRef][Medline] [Order article via Infotrieve]
  22. Kozak, M. (1987) J. Mol. Biol. 196, 947–950[CrossRef][Medline] [Order article via Infotrieve]
  23. Kozak, M. (1986) Cell 44, 283–292[CrossRef][Medline] [Order article via Infotrieve]
  24. Kozak, M. (1997) EMBO J. 16, 2482–2492[CrossRef][Medline] [Order article via Infotrieve]
  25. Kozak, M. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 7134[Abstract/Free Full Text]
  26. Geballe, A. P., and Morris, D. R. (1994) Trends Biochem. Sci. 19, 159–164[CrossRef][Medline] [Order article via Infotrieve]
  27. Morris, D. R., and Geballe, A. P. (2000) Mol. Cell Biol. 20, 8635–8642[Free Full Text]
  28. Jackson, R. J., and Standart, N. (1990) Cell 62, 15–24[CrossRef][Medline] [Order article via Infotrieve]
  29. Conne, B., Stutz, A., and Vassalli, J. D. (2000) Nat. Med. 6, 637–641[CrossRef][Medline] [Order article via Infotrieve]
  30. Stuart, J. J., Egry, L. A., Wong, G. H., and Kaspar, R. L. (2000) Biochem. Biophys. Res. Commun. 274, 641–648[CrossRef][Medline] [Order article via Infotrieve]
  31. Phelan, J. K., and Bok, B. (2000) Exp. Eye. Res. 71, 119–128[CrossRef][Medline] [Order article via Infotrieve]
  32. Di Polo, A., and Farber, D. B. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 4016–4020[Abstract/Free Full Text]
  33. Cyert, M. S. (2001) J. Biol. Chem. 276, 20805–20808[Free Full Text]
  34. Jans, D. A., Xiao, C.-Y., and Lam, M. H. C. (2000) BioEssays 22, 532–544[CrossRef][Medline] [Order article via Infotrieve]
  35. Theodorakis, N. G., Banerji, S. S., and Morimoto, R. I. (1988) J. Biol. Chem. 263, 14579–14585[Abstract/Free Full Text]
  36. Jansen, M., de Moor, C. H., Sussenbach, J. S., and van den Brande, J. L (1995) Pediatr. Res. 37, 681–686[Medline] [Order article via Infotrieve]
  37. Liebhaber, S. A., Cash, F., and Eshleman, S. S. (1992) J. Mol. Biol. 226, 609–621[CrossRef][Medline] [Order article via Infotrieve]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
L.-W. Guo, H. Muradov, A. R. Hajipour, M. K. Sievert, N. O. Artemyev, and A. E. Ruoho
The Inhibitory {gamma} Subunit of the Rod cGMP Phosphodiesterase Binds the Catalytic Subunits in an Extended Linear Structure
J. Biol. Chem., June 2, 2006; 281(22): 15412 - 15422.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Pittler, Y. Zhang, S. Chen, A. J. Mears, D. J. Zack, Z. Ren, P. K. Swain, S. Yao, A. Swaroop, and J. B. White
Functional Analysis of the Rod Photoreceptor cGMP Phosphodiesterase {alpha}-Subunit Gene Promoter: Nrl AND Crx ARE REQUIRED FOR FULL TRANSCRIPTIONAL ACTIVITY
J. Biol. Chem., May 7, 2004; 279(19): 19800 - 19807.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/39/36999    most recent
M303710200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Piri, N.
Right arrow Articles by Farber, D. B.